Back to Search
Start Over
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
- Source :
-
Blood advances [Blood Adv] 2019 Jan 22; Vol. 3 (2), pp. 132-135. - Publication Year :
- 2019
- Subjects :
- Adenine analogs & derivatives
Adult
Aged
Aged, 80 and over
Antineoplastic Agents administration & dosage
Antineoplastic Agents adverse effects
Biomarkers, Tumor
Drug Resistance, Neoplasm
Female
Humans
Lymphoma, B-Cell diagnosis
Lymphoma, B-Cell mortality
Male
Middle Aged
Piperidines
Prognosis
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors adverse effects
Pyrazoles administration & dosage
Pyrazoles adverse effects
Pyrimidines administration & dosage
Pyrimidines adverse effects
Recurrence
Retreatment
Treatment Outcome
Antineoplastic Agents therapeutic use
Genes, bcl-2
Genes, myc
Lymphoma, B-Cell drug therapy
Lymphoma, B-Cell genetics
Protein Kinase Inhibitors therapeutic use
Pyrazoles therapeutic use
Pyrimidines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2473-9537
- Volume :
- 3
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Blood advances
- Publication Type :
- Academic Journal
- Accession number :
- 30651281
- Full Text :
- https://doi.org/10.1182/bloodadvances.2018026401